INTELLIGENT BIO SOLUTIONS INC. current report, 10 February 2022

Business Context and Reporting Period

This Form 8-K is a current report filed by GBS Inc. (trading symbol: GBS) on February 10, 2022. The filing serves to announce the company's financial results for the three-month period ended December 31, 2021. The registrant is incorporated in Delaware and its common stock is listed on The NASDAQ Stock Market LLC. The company identifies itself as an emerging growth company.

Key Financial Metrics

The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the detailed financial results are contained within a press release furnished as Exhibit 99.1, which is not included in the source text provided for this summary.

Material Changes

No material changes versus prior periods are detailed in the text of this Form 8-K. The document functions solely as a notification that results for the quarter ended December 31, 2021, have been issued.

Guidance, Outlook, and Risks

The filing text does not provide management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It includes a standard disclaimer stating that the information in this report and its exhibits shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.

Investor Verification Checklist

  • Review Exhibit 99.1 (the press release dated February 10, 2022) for actual revenue, net income, and cash flow figures for the quarter ended December 31, 2021.
  • Verify the company's status as an emerging growth company and any associated reporting exemptions.
  • Confirm the trading symbol GBS on The NASDAQ Stock Market LLC.
  • Note that the filing explicitly excludes the information from being incorporated by reference into other filings unless expressly stated.